OBJECTIVE: Depression is a frequent, recurrent and chronic condition with high levels of functional disability. The Brazilian Medical Association Guidelines project proposed guidelines for diagnosis and treatment of the most common medical disorders. The objective of this paper is to present a review of the Guidelines Published in 2003 incorporating new evidence and recommendations. METHOD: This review was based on guidelines developed in other countries and systematic reviews, randomized clinical trials and when absent, observational studies and recommendations from experts. The Brazilian Medical Association proposed this methodology for the whole project. The review was developed from new international guidelines published since 2003. RESULTS: The following aspects are presented: prevalence, demographics, disability, diagnostics and sub-diagnosis, efficacy of pharmacological and psychotherapeutic treatment, costs and side-effects of different classes of available drugs in Brazil. Strategies for different phases of treatment are also discussed. CONCLUSION: The Guidelines are an important tool for clinical decisions and a reference for orientation based on the available evidence in the literature.
OBJECTIVE:Depression is a frequent, recurrent and chronic condition with high levels of functional disability. The Brazilian Medical Association Guidelines project proposed guidelines for diagnosis and treatment of the most common medical disorders. The objective of this paper is to present a review of the Guidelines Published in 2003 incorporating new evidence and recommendations. METHOD: This review was based on guidelines developed in other countries and systematic reviews, randomized clinical trials and when absent, observational studies and recommendations from experts. The Brazilian Medical Association proposed this methodology for the whole project. The review was developed from new international guidelines published since 2003. RESULTS: The following aspects are presented: prevalence, demographics, disability, diagnostics and sub-diagnosis, efficacy of pharmacological and psychotherapeutic treatment, costs and side-effects of different classes of available drugs in Brazil. Strategies for different phases of treatment are also discussed. CONCLUSION: The Guidelines are an important tool for clinical decisions and a reference for orientation based on the available evidence in the literature.
Authors: Jair de Jesus Mari; Luís Fernando Tófoli; Cristiano Noto; Li M Li; Alessandra Diehl; Angélica M Claudino; Mario F Juruena Journal: Drugs Date: 2013-09 Impact factor: 9.546
Authors: Lara F Carneiro; Maria P Mota; Felipe Schuch; Andrea Deslandes; José Vasconcelos-Raposo Journal: Braz J Psychiatry Date: 2017-08-30 Impact factor: 2.697
Authors: Cynthia B da Silva; Clarissa L Yasuda; Anelyssa D'Abreu; Fernando Cendes; Iscia Lopes-Cendes; Marcondes C França Journal: Cerebellum Date: 2013-06 Impact factor: 3.847
Authors: Thiago M Fidalgo; J Leon Morales-Quezada; Guilherme S C Muzy; Noelle M Chiavetta; Mariana E Mendonca; Marcus V B Santana; Oscar F Goncalves; Andre R Brunoni; Felipe Fregni Journal: J ECT Date: 2014-03 Impact factor: 3.635
Authors: Maria Isabel Perez Mattos; Bruno Paz Mosqueiro; Scott Stuart; Giovanni Salum; Rosana de Lima Duzzo; Laura Wolf de Souza; Ariane Chini; Marcelo Pio de Almeida Fleck Journal: Rev Saude Publica Date: 2022-04-22 Impact factor: 2.106
Authors: Nicoli Abrão Fasanella; Clarissa Garcia Custódio; Júlia Santos do Cabo; Gabriel Sousa Andrade; Fernando Antônio de Almeida; Maria Valéria Pavan Journal: Sao Paulo Med J Date: 2022 Sep-Oct Impact factor: 1.838